Screener
Xeris Biopharma Holdings, Inc. XERS Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Xeris Biopharma Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Xeris Biopharma Holdings, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001867096-26-000065
FAQ
- What is Xeris Biopharma Holdings, Inc.'s total assets?
- Xeris Biopharma Holdings, Inc. (XERS) reported total assets of $411.91M in Q2 2026.
- How has Xeris Biopharma Holdings, Inc.'s total assets changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s total assets increased by 23.1% year-over-year, from $334.69M to $411.91M.
- What is the long-term trend for Xeris Biopharma Holdings, Inc.'s total assets?
- Over 5 years (2020 to 2025), Xeris Biopharma Holdings, Inc.'s total assets has grown at a 19.2% compound annual growth rate (CAGR), from $159.15M to $383.53M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Xeris Biopharma Holdings, Inc.'s total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude